Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 216
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending
Weekly Psychedelic Policy Briefing: Oct. 27, 2026
Pharma Moves In: Investors, Developers and Lilly’s Carole Ho at the Psychedelic Healthcare Forum
Mostly Supportive, Somewhat Divided: Stakeholders Respond to FDA’s Psychedelics Docket
New Study: LSD Makes Brain Rhythms Faster and Increases Neural Complexity
Nova Mentis Provides Corporate Update – 2022 Planned Catalysts
Filament Health and Cybin Therapeutics Announce Licensing Agreement
Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule...
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary...
PharmaDrug Announces Resignation of Director
PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care
Mydecine to Launch Special Access Support and Supply Program in Canada...
MYND Life Sciences Announces Collaborative Research Agreement with the University of...
atai Life Sciences announces FDA Investigational New Drug (IND) Clearance for...
Load more